Bruker Corp. (NASDAQ:BRKR)

CAPS Rating: 3 out of 5

The Company designs, manufactures, services and markets analytical and life science systems and associated products to address the needs of its customers in life science research, pharmaceutical, biotechnology and molecular diagnostics research.

Recs

0
Player Avatar at38lantis (< 20) Submitted: 5/29/2009 1:00:27 PM : Outperform Start Price: $6.50 BRKR Score: +86.35

Continued development of superb products and outstanding marketing along with joint development agreements will help PUSH Bruker

Featured Broker Partners


Advertisement